Tag Archives: 09/2015

Report from the Strategy Seminar

Eystein 2The Strategy Seminar last week was informative and useful. Vice Dean for Research at Karolinska Institutet (KI) Hans-Gustaf Ljunggren gave an engaging talk about KI’s research strategy. Their starting point was to acknowledge that KI did not excel in medical research to the degree that KI thought themselves. Systematic bibliographic analyses of publication activity revealed that they had a strong position in Europe, but several universities with which they liked to be compared to, did better. KI defined as its goal to become as good as University of Oxford with regards to “impact” of publications. To reach this goal they decided to publish fewer, but better articles – in other words, more articles that bring significant new knowledge to the field and therefore reach the most prestigious journals. KI viewed their PhD-programs’ demand for 3-4 articles as an obstacle – “it is better to publish one high-impact article than 3-4 articles of lesser importance”. KI has now removed the demand for a minimum number of articles in PhD-theses. Furthermore, KI wishes to recruit active research leaders and now work very actively with recruitment of such persons. A “starting package” often is in the order of 10 million per year for 3-5 years. Such a package is often composed of both university- and external funding, but it should be noted that KI is in charge of the strategy and the evaluation of candidates. At the same time KI has a keen eye also on the groups who perform badly, and take action. Sometimes such groups merged with stronger groups, other times they are dismantled.

 ViceRector Anne Lise Fimreite talked about UiB’s strategy process. UiB aims to build up strong research clusters. One of these is called Health, and will focus on research related to health services (Samhandlingsreformen). The strategy document will soon be out on hearing, which gives you a chance to submit your views.

 Finally the Pharmaceutical Industry informed of their interest in increased interaction with academic institutions; they wish to establish a pilot center for such collaboration in Bergen. It will be exciting to learn more about this in the near future.

 Finally there was a workshop and discussion on the department’s organization. I expected both criticism and creative suggestions for changes, but it appeared that most people were satisfied with today’s organization. The discussion was rather tame, but one conclusion emerged – if K2 is to improve we have to collaborate better; everyone must contribute to do the work.

 Eystein Husebye

 Head of Department


We wish to invite everyone to the K1/K2 seminar series!

 Next seminar:
Title: “Genetic alterations causing resistance to chemotherapy in breast
 Held by Stian Knappskog.
Section of Oncology, K2, UiB / Mohn Kreftforskningslab., HUS
When: Wednesday 4th of March, 14:15 – 15:00.
Where: Stort Auditorium, 3rd floor, Sentralblokken
Chair: Pål Njølstad

  Continue reading

New PhD-Coordinator at Department of Clinical Science

Present PhD-Coordinator Kristian Jensen will start a new job on 01.05.2015.  Higher Executive Officer Irene Lavik Hjelmaas will then take over all PhD-related tasks.  Kristian will also be absent between 27.02.2015 – 06.04.2015, so during this period Irene may also be contacted regarding PhD-related inquiries.  Irene may be reached at phone 55 58 88 46 or e-mail  Irene Hjelmaas

Public defence Week 10

Carla FernandesCarla Patrica Duarte Fernandes will have her public defence on Thursday March 5, 2015
Trial lecture: Thursday March 5 2015, kl.09.15
Topic: ”Genomics neurodevelopment and neuropsychiatry – what studies of cognition can tell us about psychosis risk”
Place: Auditoriet, Barneklinikken, Jonas Lies vei 65
Public defence: Thursday March 5 2015, kl.11.15
Place: Auditoriet, Barneklinikken, Jonas Lies vei 65
Title of dissertation: ”A Genetic  study of schizophrenia and bipolar disorder.  A cognitive endophenotype approach”
1st opponent Professor Gary Donohoe, National  University of Ireland
2nd opponent Ph.d. Robert Lyle, Universitetet i Oslo

Press relase




Public defence Week 10

Sivakumaran, DhanasekaranDhanasekaran Sivakumaran will have his public defence on Thursday March 5, 2015
Trial lecture: Thursday March 5, 2015,kl. 09:15
Topic: ”Tuberculosis and latent tuberculosis infection: dignostic strategies in high- and low endemic settings”
Place: Audtorium 1, Bygg for biologiske basalfag
Public defence: Thursday March 5, 2015 kl. 11.15
Place: Audtorium 1, Bygg for biologiske basalfag
Title of dissertation: ”Biomarkersof mycobacterium tuberculosis infection and disease in children in Southern India”
1st  Opponent: MD, Ph.D. Søren Tetens Hoff, Statens Serum Institute, København, Danmark
2nd. Opponent :Ph.D Ulf R. Dahle Folkehelseinstituttet

 Press relase


Public defence Week 10

Jan Anker JahnsenJan Anker Jahnsen will have his public defence on Friday March 6, 2015
Trial lecture: Thursday March 5, 2015, 15.15
Topic: ”Topogy and pharmacological importance of ionotropic glutamate channels (NMDA and AMPA receptors)”
Place: Auditorium 1, Bygg for Biologiske basalfag
Public defence: Friday March 6, 2015, 10.15
Place: Audtorium 1, Bygg for biologiske basalfag
Title of dissertation: ”Predicted signal peptides, and the role of the N-terminal tail, at the monoamine G-protein coupled receptors 5-HT 2C and a 2c”
1st  Opponent: Proffesor Dan Larhammar, Uppsala Universitet, Sverige
2nd. Opponent : Professor emeritus Ole Jacob Broch, Bergen

 Press relase


New Publications

Week 09/2015.

Global Coronary Artery Plaque Area is Associated with Myocardial Hypoperfusion in Women with Non-ST Elevation Myocardial Infarction.
Eskerud I, Gerdts E, Nordrehaug JE, Lønnebakken MT.
J Womens Health (Larchmt). 2015 Feb 18. PMID: 25692527

Based on last week’s search forDepartment of Clinical Science AND Bergen”. If you have publications which are not covered by this search, send the reference to olivera.bozickovic@k2.uib.no